Skip to main content

Table 1 Baseline characteristics of the screening participants stratified by the results of the PG tests

From: Brand interchangeability of pepsinogen tests in the real-world setting after eradication of Helicobacter pylori: a community-based study

Screening participants

Participants (n = 5117)

Negative result (n = 4833)

Positive result* (n = 284)

P value†

Mean age, years (SD; range)

55.0 (12.9; 30–100)

54.8 (12.9; 30–100)

58.1 (13.5; 30–96)

< 0.001

Male sex, no. (%)

2510 (49.1)

2364 (48.4)

146 (51.4)

0.33

Body mass index, kg/m2 (SD; range)

25.1 (4.0; 14.6–52.1)

25.1 (4.0; 14.6–52.1)

25.1 (3.9; 15.8–37.5)

0.93

Social habits, no. (%)

 Current smoker

752 (14.7)

708 (14.6)

44 (15.5)

0.68

 Regular alcohol drinking

320 (6.3)

307 (6.3)

13 (4.6)

0.25

 Betel nut chewing

221 (4.3)

208 (4.3)

13 (4.6)

0.81

Medical history, no. (%)

 Hypertension

1553 (30.3)

1443 (29.9)

110 (38.7)

0.002

 Diabetes mellitus

464 (9.1)

441 (9.1)

23 (8.1)

0.57

 Hyperlipidemia

375 (7.3)

346 (7.2)

29 (10.2)

0.06

 Cardiovascular disease

269 (5.3)

253 (5.2)

16 (5.6)

0.77

 Stroke

30 (0.6)

29 (0.6)

1 (0.4)

0.67

 Chronic hepatitis B

626 (12.2)

586 (12.1)

40 (14.1)

0.32

 Chronic hepatitis C

27 (0.5)

24 (0.5)

3 (1.1)

0.18

 Chronic kidney disease

56 (1.1)

54 (1.1)

2 (0.7)

0.53

  1. SD standard deviation
  2. *Test positives for either GastroPanel (Biohit HealthCare, Helsinki, Finland) or LZ-Test (Eiken Chemical Co., Ltd, Tokyo, Japan)
  3. †P < 0.05 in the comparison between the test positives and negatives